Amy Abernethy, MD, PhD, adjunct professor of medicine (Medical Oncology) and a Duke University School of Medicine alumna, has been appointed the FDA’s new principal deputy commissioner of food and drugs. Her appointment will begin early next year.
A journal article by Thomas LeBlanc, MD, associate professor of medicine (Hematologic Malignancies and Cellular Therapy), and Amy Abernethy, MD, adjunct professor of medicine (Medical Oncology), has been recognized as a paper that could "Change the World, One Article At A Time" by Springer Nature journals.
Medicine Grand Rounds on Fri., July 18 at 8 a.m.
The Centers for Medicare and Medicaid Services has awarded a CMS Health Care Innovation award, worth $9.6 million, to the DCRI’s Center for Learnin
Peter Ubel, MD, professor of business administration, medicine and publi
Amy Abernethy, MD, associate professor of medicine (Medical Oncology) and director of both the Center for Learning Health Care and
Duke Center for Palliative Care's new outpatient palliative care program was recently feature
Amy Abernethy, MD, associate professor of medicine (Medical Oncology) and director